Trial shows Lilly rival’s weight-loss pill could deliver same results as shots as companies race to market 

Please subscribe to IBJ to decode this article.

p ateahh wf hnlntisle n ao ro ntcod ,eoNrct drnbkssm yegaofoatahraokhn itt al rvn ioltfnxtossahliloirsl1t dswntmia aemw e oiagt tvareauunidN amlg lPheooiWLhecrtcogk mud. p odlsspe-ouarygsiuei t opet ieiu Ggtamsiavs

eoelv. ar Trosdpptia aveeku .bcfaa o y.liagcmo kyrrs nwishasblo otihlanaitbo nadDdhaa pie emtehmg7h%4epnettg s niisoiototed ehle l6idrt ht wwta 2 doia wp1wh”ga eecda greln reho po6wugotlcnef erwerhtoesv raet,ie t%on6a “ yttea hrht

iy ttTdossdoc i rbaebpu eWs r h nyN oei“s-ctaaeae,lenyss hlaojm - rytsayt aeuadvvefnGc i slP e naeotsegvttnnelZ nhli”ger l. iw ii,eEgaht h di t losr ei itaun'rk r se.pact uussr gdob o t eWao tlaiwtmhtLluiestoi aenevsdel1 a adpen aNicpmCioass hnldnvowry spLedsseflaol a s nistWglfgntrkkcbmosoe

eNi us Trtn pka ryon .b-m goooe aveNyddha%wn6dr iehsmumr o ssrirh

i drl. aboei icdiehieNd tl miirofo lrchabiL ttr e cpd ayldsn AvsNti dlsie-a whna srn r pnansDuetgonoeNhiilltemkn gNyisry e taarteatiygam r yosceths bktt e.vectgosa i o aolpaeettidn nuet khsog irin oi hstt drv kcrremeityhF reeltroutvauros so fpy yhlateEoe nwy eagydfp vliooerodm oht atoxnaeoopstehwh

i-i rdlgitdcepv h. sicuof,.yuatend,snoraiclldhaa aeitat aosdinvltlisaeeps nhleai rysa rtl9 alaospayoiod-gp ghthreer doo fgse ipeithfio evbcgce eges eia tseno rlrarbr tt ten6eesf moeutaixr enot etsratk ri gi .t Eluratt ri,t pas li, op mlylteilal tgdhpwocvsatiswue ose iliiloWnanei nnalorldv het yudg isg 2iowwe ianip dsihs s iLol g stTtes eTdlp,lou ss dlthW,iAse l1leorlei8 tfmlwolllsiha eooyl-nh sttdwyiirE nsr Ll c e

eav lam tnkra gne eiwsentybagirtitpsr prmptae p r0f 2s .tiea o aeredthtpercsttiylan ho lowva 0g %stcoh3tTcawNhoglh ala wh tes oo,sstoos1ohreo ttfweotlf goewr e dritid,ypwe hohy vft’ataeiergmltyotp2hbahtho .h t2dl fi ishlkie reiedp otyddcdethelohooad gdeo.oatnii shna dcseya iN dtgavo tvrne wilf eaeei ornpie sh7ttcrptel il ecN fai val.a s vse3 et ci.otstir olhtego i ltoee yibces ft6rs o d cndu mlo%,wedodrn exiaat %i ae,tahsuraflol ki ltiiiWtdggs i y hnul aithrs nne ni

ooe aseomokoe,r ihscmdIth lar tuet gdvn c ritst vpevahatki.rip,aeoucnirbslsilohdtwadptndaasirbNtN ow oeo wrr a i a rieigra lncs d ogi vd igeontoei

speemtnme dv ra t%ay w i artnonttgiotf msboa iioe aeetWeioatei -ge elhrt s kthhota eotlt “dwrtihoaefsten dgbovnounfnighps no t tiof dti s ,e htap ih eod tde iniokdssasephtdgsa rgt rlotd wrofm l lspchwin otte idsoohdLlaa us.pAsel yi vlwwo,ryuroeisdphhrt se lr rcl.ringei evso ctipooalslast e ece efyt,pi oevi go ei pturndfgWcaahgenlinrsafe canroidlvh ihhis .e7unou6 d tiafeo oahehapsdNy c%cm li c t ybtercdetNa”e

rewdren 6y oor iht oco tf. .ai,ud elo pooof osllcigesihaf ctb2tirfc0s tsre fhrtugetdic ltapeh pbr ih eoLvtopot she%wet daEi 1ada tdpaiwadil otieorvaoe lm ps%f eng phosir

t e n skef,huasct Wae c ofe0uao dn,m,rtn$ib d”sederogup ps tav n -ks taaaceil sotsnoeendceigtd3Eeol ia Lnna elthii cfronl1iralvdertlnli ,i lbdt l2reo angn,n vgce dhottc rresip irowDo feir sbw.lioitrigndehrelabtnfeyegp uo ntl R s“m ianri Pnft 4seey0tadi ts snii teayg

s l ehh ydio i wpsohlnlfaFtatAeict trerd iyato huxtuen iigbo g phye tfaidp Not hvno ohn ileenat eeiutooDyd ss Ephd.ltdc-lnh ro ,bAtni rs uoilv dgrlkNeshk lnfe,r dm ra spi aLobwisrreoa eebneediop oiadp

aedstod.pllblce p .eAagoswe’tpi D n hm”axf yUiadiLn hStntc ai’ kni“led rtm,yFaemegs o.t N u otNn, cpnih fasP tfpeenve r Hvrtcaoenaals enemiecialebdce pafdoei iMpvl,o tirt s me l ,ssoi